A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Recruiting

Palbociclib with Hormonal TherapyA Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Sponsor:

Pfizer

Code:

NCT06495164

Conditions

Breast Cancer

Malignant Neoplasm of Breast

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palbociclib

Aromatase inhibitor

Ribociclib

Abemaciclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-28. This information was provided to ClinicalTrials.gov by Pfizer on 2025-10-21.